Safety and Efficacy of BIND-014, a Docetaxel Nanoparticle Targeting Prostate-Specific Membrane Antigen for Patients With Metastatic Castration-Resistant Prostate Cancer: A Phase 2 Clinical Trial Academic Article uri icon

Overview

MeSH Major

  • Bone Neoplasms
  • Bone and Bones
  • Prostatic Neoplasms

abstract

  • ClinicalTrials.gov Identifier: NCT01812746.

publication date

  • October 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1001/jamaoncol.2018.2168

PubMed ID

  • 29978216

Additional Document Info

start page

  • 1344

end page

  • 1351

volume

  • 4

number

  • 10